|
Real-time
Euronext Paris
11:26:38 2026-08-31 EDT
|
5-day change | 1st Jan Change | ||
| 0.2010 EUR | 0.00% |
|
-14.83% | -14.10% |
| 07-30 | Poxel S.A. Reports Sales Results for the Quarter Ended 30 June 2026 | CI |
| 07-30 | Poxel SA Delays Earnings Results Release for the 2025 Financial Statements | CI |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 12.53M | - | - | - | - | - |
| 69.54B | |||||
| 64.97B | |||||
| 26.51B | |||||
| 25.89B | - | ||||
| 25.64B | - |
- Stock Market
- Stocks
- POXEL Stock
- Charts Poxel
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
